Buy & Sell BioNano Genomics Inc (BNGO) – BioNano Genomics Inc Price Today
Aura AI Summary
Key Stats
- $12.85MMarket Cap
- HealthSector
- -15.79%3M Drawdown
- $15.46MEnterprise Value
- -Dividend Yield
- 100% Buy | 0% SellTrading Activity
- 44 daysTypical Hold Time
BioNano Genomics Inc (BNGO) is currently valued at a market capitalization of $12.85M, with an enterprise value of $15.46M. Over the past 52 weeks, BioNano Genomics Inc has traded between a low of $1.09 and a high of $4.92, highlighting its annual price range. Over the past three months, BioNano Genomics Inc has recorded a drawdown of -15.79%, reflecting recent price volatility. On average, investors hold BioNano Genomics Inc for approximately 44 days, indicating typical investor behavior on the platform.
About BioNano Genomics Inc
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.
Most Recent News
Complex small molecules reshape drug R&D, demanding integrated discovery to manufacturing solutions.
WuXi AppTec highlights how the increasing structural complexity of small molecules, such as targeted protein degraders and covalent inhibitors, is transforming drug research and development. These new molecules require advanced, integrated approaches...

Axsome starts Phase 3 trial of solriamfetol for ADHD in adolescents, aiming to improve treatment options.
Axsome Therapeutics has initiated the FOCUS-3 Phase 3 clinical trial to evaluate solriamfetol as a treatment for adolescents aged 12 to under 18 with ADHD. This randomized, double-blind, placebo-controlled study will enroll about 468 patients to asse...

SoundHound AI's COO sells 65,000 shares, signaling insider stock movement.
SoundHound AI's Chief Operating Officer has sold 65,000 shares of the company's stock. This insider sale could indicate personal financial decisions or a strategic move related to the company's outlook. Investors often watch such transactions closely...
